Obesity and prostate cancer aggressiveness among African and Caucasian Americans in a population-based study

Cancer Epidemiology Biomarkers and Prevention

Volumn 20, Issue 5, 2011, Pages 844-853

  Su, L Joseph ^a   Arab, Lenore ^b   Steck, Susan E ^c   Fontham, Elizabeth T H ^a   Schroeder, Jane C ^d   Bensen, Jeannette T ^e   Mohler, James L ^e,f,g  

^a LSUHSC School of Public Health   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF SOUTH CAROLINA   (United States)

^d IL   (United States)

^e UNIVERSITY OF NORTH CAROLINA   (United States)

^f ROSWELL PARK CANCER INSTITUTE   (United States)

^g UNIVERSITY AT BUFFALO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT;

ADULT; AFRICAN AMERICAN; AGGRESSIVENESS; ARTICLE; BODY MASS; BODY WEIGHT; BRACHYTHERAPY; CANCER DIAGNOSIS; CANCER HORMONE THERAPY; CANCER INCIDENCE; CANCER RADIOTHERAPY; CANCER SURGERY; COMPARATIVE STUDY; CONFOUNDING VARIABLE; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE SEVERITY; EUROPEAN AMERICAN; HUMAN; MAJOR CLINICAL STUDY; MALE; OBESITY; PRIORITY JOURNAL; PROSTATE CANCER; WAIST HIP RATIO;

AFRICAN AMERICANS; BODY MASS INDEX; CROSS-SECTIONAL STUDIES; EUROPEAN CONTINENTAL ANCESTRY GROUP; HUMANS; INCIDENCE; LOUISIANA; MALE; MIDDLE AGED; NORTH CAROLINA; OBESITY; POVERTY; PREVALENCE; PROSTATE-SPECIFIC ANTIGEN; PROSTATIC NEOPLASMS; RISK FACTORS; WAIST-HIP RATIO;

EID: 79955755268     PISSN: 10559965     EISSN: None     Source Type: Journal    
DOI: 10.1158/1055-9965.EPI-10-0684     Document Type: Article

References (40)

1. Bray GA. The underlying basis for obesity: relationship to cancer. J Nutr 2002;132:3451S-5S.
2. Giovannucci E, Liu Y, Platz EA, Stampfer MJ, Willett WC. Risk factors for prostate cancer incidence and progression in the health professionals follow-up study. Int J Cancer 2007;121:1571-8. (Pubitemid 47328718)
3. Calle EE, Rodriguez C, Walker-Thurmond K, Thun MJ. Overweight, obesity, and mortality from cancer in a prospectively studied cohort of U.S. adults. N Engl J Med 2003;348:1625-38. (Pubitemid 36459468)
4. Jayachandran J, Bañez LL, Aronson WJ, Terris MK, Presti JC, Amling CL, et al. Obesity as a predictor of adverse outcome across black and white race: results from the Shared Equal Access Regional Cancer Hospital (SEARCH) Database. Cancer 2009;115:5263-71.
5. Gallina A, Karakiewicz PI, Hutterer GC, Chun FK, Briganti A, Walz J, et al. Obesity does not predispose to more aggressive prostate cancer either at biopsy or radical prostatectomy in European men. Int J Cancer 2007;121:791-5. (Pubitemid 47106208)
6. Ly D, Reddy CA, Klein EA, Ciezki JP. Association of body mass index with prostate cancer biochemical failure. J Urol 2010;183:2193-9.
7. Wallstrom P, Bjartell A, Gullberg B, Olsson H, Wirfalt E. A prospective Swedish study on body size, body composition, diabetes, and prostate cancer risk. Br J Cancer 2009;100:1799-805.
8. Freedland SJ, Platz EA. Obesity and prostate cancer: making sense out of apparently conflicting data. Epidemiol Rev 2007;29:88-97. (Pubitemid 47229642)
9. Littman AJ, White E, Kristal AR. Anthropometrics and prostate cancer risk. Am J Epidemiol 2007;165:1271-9. (Pubitemid 47234324)
10. MacInnis RJ, English DR. Body size and composition and prostate cancer risk: systematic review and meta-regression analysis. Cancer Causes Control 2006;17:989-1003. (Pubitemid 44290764)
11. Demark-Wahnefried W, Moyad MA. Dietary intervention in the management of prostate cancer. Curr Opin Urol 2007;17:168-74. (Pubitemid 46597436)
12. Algarte-Genin M, Cussenot O, Costa P. Prevention of prostate cancer by androgens: experimental paradox or clinical reality. Eur Urol 2004;46:285-94; discussion 294-5.
13. Massengill JC, Sun L, Moul JW, Wu H, McLeod DG, Amling C, et al. Pretreatment total testosterone level predicts pathological stage in patients with localized prostate cancer treated with radical prostatectomy. J Urol 2003;169:1670-5. (Pubitemid 36443468)
14. Hsing AW, Gao YT, Chua S Jr, Deng J, Stanczyk FZ. Insulin resistance and prostate cancer risk. J Natl Cancer Inst 2003;95:67-71. (Pubitemid 36124297)
15. Fowke JH, Signorello LB, Underwood WIII, Ukoli FA, Blot WJ. Obesity and prostate cancer screening among African-American and Caucasian men. Prostate 2006;66:1371-80. (Pubitemid 44350362)
16. Jemal A, Siegel R, Ward E, Murray T, Xu J, Smigal C, et al. Cancer statistics, 2006. CA Cancer J Clin 2006;56:106-30.
17. Schroeder JC, Bensen JT, Su LJ, Mishel M, Ivanova A, Smith GJ, et al. The North Carolina-Louisiana Prostate Cancer Project (PCaP): methods and design of a multidisciplinary population-based cohort study of racial differences in prostate cancer outcomes. Prostate 2006;66:1162-76. (Pubitemid 44175339)
18. Reisch LM, Fosse JS, Beverly K, Yu O, Barlow WE, Harris EL, et al. Training, quality assurance, and assessment of medical record abstraction in a multisite study. Am J Epidemiol 2003;157:546-51. (Pubitemid 36292914)
19. World Health Organization. Definition, Diagnosis and Classification of Diabetes Mellitus and Its Complications: Report of a WHO Consultation. Geneva, Switzerland: Department of Noncommunicable Disease Surveillance, World Health Organization; 1999.
20. Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 1987;40:373-83. (Pubitemid 17055592)
21. Freeman VL, Durazo-Arvizu R, Keys LC, Johnson MP, Schafernak K, Patel VK. Racial differences in survival among men with prostate cancer and comorbidity at time of diagnosis. Am J Public Health 2004;94:803-8.
22. Ainsworth BE, Haskell WL, Whitt MC, Irwin ML, Swartz AM, Strath SJ, et al. Compendium of physical activities: an update of activity codes and MET intensities. Med Sci Sports Exerc 2000;32:S498-504.
23. Littman AJ, Kristal AR, White E. Recreational physical activity and prostate cancer risk (United States). Cancer Causes Control 2006;17:831-41.
24. Giovannucci E, Rimm EB, Stampfer MJ, Colditz GA, Willett WC. Height, body weight, and risk of prostate cancer. Cancer Epidemiol Biomarkers Prev 1997;6:557-63. (Pubitemid 27342677)
25. Robinson WR, Stevens J, Gammon MD, John EM. Obesity before age 30 years and risk of advanced prostate cancer. Am J Epidemiol 2005;161:1107-14. (Pubitemid 40847338)
26. Gong Z, Neuhouser ML, Goodman PJ, Albanes D, Chi C, Hsing AW, et al. Obesity, diabetes, and risk of prostate cancer: results from the prostate cancer prevention trial. Cancer Epidemiol Biomarkers Prev 2006;15:1977-83. (Pubitemid 44664277)
27. Wright ME, Chang SC, Schatzkin A, Albanes D, Kipnis V, Mouw T, et al. Prospective study of adiposity and weight change in relation to prostate cancer incidence and mortality. Cancer 2007;109:675-84. (Pubitemid 46233228)
28. Freedland SJ, Terris MK, Presti JC, Amling CL, Kane CJ, Trock B, et al. Obesity and biochemical outcome following radical prostatectomy for organ confined disease with negative surgical margins. J Urol 2004;172:520-4. (Pubitemid 38900194)
29. Freedland SJ, Aronson WJ, Kane CJ, Presti JC, Amling CL, Elashoff D, et al. Impact of obesity on biochemical control after radical prostatectomy for clinically localized prostate cancer: a report by the Shared Equal Access Regional Cancer Hospital database study group. J Clin Oncol 2004;22:446-53. (Pubitemid 41079773)
30. Amling CL, Riffenburgh RH, Sun L, Moul JW, Lance RS, Kusuda L, et al. Pathologic variables and recurrence rates as related to obesity and race in men with prostate cancer undergoing radical prostatectomy. J Clin Oncol 2004;22:439-45. (Pubitemid 41079772)
31. Satia-Abouta J, Patterson RE, Schiller RN, Kristal AR. Energy from fat is associated with obesity in U.S. men: results from the Prostate Cancer Prevention Trial. Prev Med 2002;34:493-501. (Pubitemid 34971670)
32. Gapstur SM, Gann PH, Kopp P, Colangelo L, Longcope C, Liu K. Serum androgen concentrations in young men: a longitudinal analysis of associations with age, obesity, and race. The CARDIA male hormone study. Cancer Epidemiol Biomarkers Prev 2002;11:1041-7. (Pubitemid 35192655)
33. Werny DM, Thompson T, Saraiya M, Freedman D, Kottiri BJ, German RR, et al. Obesity is negatively associated with prostate-specific antigen in U.S. men, 2001-2004. Cancer Epidemiol Biomarkers Prev 2007;16:70-6.
34. Amling CL, Kane CJ, Riffenburgh RH, Ward JF, Roberts JL, Lance RS, et al. Relationship between obesity and race in predicting adverse pathologic variables in patients undergoing radical prostatectomy. Urology 2001;58:723-8.
35. Fowke JH, Motley SS, Wills M, Cookson MS, Concepcion RS, Eckstein CW, et al. Prostate volume modifies the association between obesity and prostate cancer or high-grade prostatic intraepithelial neoplasia. Cancer Causes Control 2007;18:375-84. (Pubitemid 46434798)
36. Rundle A, Richards C, Neugut AI. Body composition, abdominal fat distribution, and prostate-specific antigen test results. Cancer Epidemiol Biomarkers Prev 2009;18:331-6.
37. Stevens J, Juhaeri Cai J, Jones DW. The effect of decision rules on the choice of a body mass index cutoff for obesity: examples from African American and white women. Am J Clin Nutr 2002;75:986-92. (Pubitemid 34547526)
38. Efstathiou JA, Bae K, Shipley WU, Hanks GE, Pilepich MV, Sandler HM, et al. Obesity and mortality in men with locally advanced prostate cancer: analysis of RTOG 85-31. Cancer 2007;110:2691-9. (Pubitemid 350250338)
39. Fowke JH, Signorello LB, Chang SS, Matthews CE, Buchowski MS, Cookson MS, et al. Effects of obesity and height on prostate-specific antigen (PSA) and percentage of free PSA levels among African-American and Caucasian men. Cancer 2006;107:2361-7. (Pubitemid 44748518)
40. Sequoia JS, Wright ME, McCarron P, Pietinen P, Taylor PR, Virtamo J, et al. A prospective investigation of height and prostate cancer risk. Cancer Epidemiol Biomarkers Prev 2006;15:2174-8. (Pubitemid 44877043)